Oricell Therapeutics raises $110 million for solid tumor CAR-T
April 10, 2026 | 09:09
The cell therapy company secured pre-listing funding to advance clinical development of engineered immune treatments for non-blood cancers globally.
China to approve world's first solid tumor CAR-T therapy
April 10, 2026 | 09:04
Regulatory clearance for the engineered immune cell treatment targeting non-blood cancers is expected imminently in the country.
Mobile Version